Weekly Spotlight - 21.11.24

Community Voices

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Boy with Fabry Disease and Rare Blood Disorder Highlights Complex Diagnosis Challenges

A 10-year-old boy was diagnosed with Fabry disease along with a rare blood disorder, highlighting the complexities of diagnosing and managing co-occurring conditions. The case study emphasizes the importance of comprehensive medical evaluations to identify multiple health issues in patients with Fabry disease.

CDSCO Panel Warns Takeda Biopharm About Risks of Self-Administration of Agalsidase Alfa

A regulatory panel in India has advised Takeda Biopharm to inform patients about the potential risks associated with self-administering Agalsidase Alfa, a treatment for Fabry disease. The panel emphasizes the need for clear instructions and warnings to ensure patient safety during home administration.

Fabry Disease Treatment Market: Growth and Restraint Factors

The article discusses the current state and future outlook of the Fabry disease treatment market. It highlights factors driving market growth, such as increasing awareness and diagnosis, as well as constraints like high treatment costs and limited availability of therapies. The report also analyzes key players and potential new treatments.

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter Financial Results

Sangamo Therapeutics has released its third-quarter financial results and business highlights. The report includes updates on the company's gene therapy programs, including those for Fabry disease, as well as its financial performance and upcoming milestones. The company is progressing with clinical trials and expanding its research collaborations.